The $95 Laryngoscope

I run IntuBlade, so I have obvious bias here. So I need to be precise.

This is not a clinical superiority claim for IntuBlade, and it is not a substitute for regulatory labeling. The $95 number is the price point I built the access thesis around. Commercial and regulatory status still matter before any device becomes real medicine.

But the airway problem that pushed me into building it was real. Video laryngoscopy was available, clinically useful, and still out of reach for too many EMS systems. Not because medics didn't understand the value. Because the total package was too expensive and too annoying.

The device. The screen. Cleaning. Charging. Repairs. Replacement. Training. Procurement. Somebody finding the cable that was supposed to stay with the unit.

Medicine loves to pretend adoption is mostly about evidence. It usually isn't. Evidence matters, but the thing that gets used is the thing a department can afford, train, stock, replace, and keep alive in the real workflow.

The Field Is the Worst Place to Ration Visualization

Video laryngoscopy is common in hospitals. The field is where the margin is thinner. In an ED, you usually have light, help, backup equipment, respiratory therapy, and people who can rescue a bad airway.

In the field, the airway might be in a truck, a ditch, a bedroom, a stairwell, or the back corner of a house. None of those places were built with laryngoscopy in mind. That is exactly where visualization should not be treated like a premium feature.

But it often is. For a smaller agency, a few thousand dollars per reusable unit can kill the conversation before anyone gets to training or outcomes. The question stops being "Would video help?" It becomes "Can we buy enough units to make this operationally real?"

That is the question that decides what medics carry.

The Product Bet

IntuBlade is the product thesis: a single-use USB-C video laryngoscope. The design assumption is simple. Plug into a phone or tablet. Get a video airway view. Dispose of the blade after use. No cleaning cycle. No battery management. No repair queue.

The price point I care about is $95 per blade. That number matters because access is math before it is a slogan. A department that couldn't justify one expensive reusable scope can start thinking about video on every truck.

That changes the deployment conversation from "Who gets the special device?" to "Why would any airway not have video available?" That is the standard I care about.

Stocking ratio matters here. One scope in a supervisor bag is not the same thing as airway video available where the patient is. EMS products have to survive per-truck economics, backup stock, replacement, and the person who has to reorder the thing after a bad week.

Simplicity Is a Clinical Feature

I don't think simplicity gets enough respect in medical devices. It is treated like a nice-to-have. In EMS, it is survival.

If setup is fussy, the device loses. If replacement is painful, the device loses. If training turns into one more thing a supervisor has to drag across a county, the device loses. If the screen, charger, blade, handle, and cleaning process all depend on perfect behavior from tired humans, the device loses.

People don't adopt devices in a vacuum. They adopt them inside already-stressed systems. That is why "cheap" is not the whole argument. Cheap and annoying still fails. Cheap, simple, stocked, and easy to say yes to has a shot.

What I Think Device Teams Miss

A lot of medical device companies build for the buying committee slide deck. Better image. Better feature. Better spec. Fine. Specs matter.

But in the field, deployment decides whether the device becomes medicine or inventory.

Does it fit the truck?

Can the agency afford enough of them?

Can a medic use it without asking where the proprietary cable went?

Can the chief replace it without a capital request?

Does it create new work for people who are already behind?

Those are not secondary questions. They are the product.

Why I Still Care About This Category

The broken part was never that video laryngoscopy didn't exist. The broken part was access. That is still where the work is.

Regulatory path. Manufacturing. Packaging. Pricing. Training. Donation channels. Distribution. All the unglamorous pieces that decide whether a useful airway tool actually reaches the people who need it.

I care more about that than making a prettier premium device for systems that already have options. Some medical technology needs to be more advanced. Some of it needs to be plain enough, cheap enough, and deployable enough that it finally shows up.